(Q41618926)

5 October 2017

1 reference

title

Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitus (English)

1 reference

5 October 2017

Wilde MI

1

1 reference

5 October 2017

McTavish D

series ordinal

2

1 reference

5 October 2017

publication date

1 October 1997

1 reference

5 October 2017

1 reference

5 October 2017

volume

54

1 reference

5 October 2017

issue

4

1 reference

5 October 2017

page(s)

597-614

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199754040-00006

5 October 2017

exact match

0 references

cites work

Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.

1 reference

12 December 2020

Lispro, a rapid-onset insulin

1 reference

12 December 2020

Insulin lispro in CSII: results of a double-blind crossover study

1 reference

12 December 2020

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

12 December 2020

Lys(B28), Pro(B29)-human insulin: Effect of injection time on postprandial glycemia

1 reference

12 December 2020

Improved mealtime treatment of diabetes mellitus using an insulin analogue. Multicenter Insulin Lispro Study Group

1 reference

12 December 2020

Counterregulatory hormone responses and symptoms during hypoglycaemia induced by porcine, human regular insulin, and Lys(B28), Pro(B29) human insulin analogue (insulin Lispro) in healthy male volunteers

1 reference

12 December 2020

The human insulin analog insulin lispro improves insulin binding on circulating monocytes of intensively treated insulin-dependent diabetes mellitus patients

1 reference

12 December 2020

1 reference

12 December 2020

Stability of insulin lispro in insulin infusion systems.

1 reference

12 December 2020

Role of C-terminal B-chain residues in insulin assembly: the structure of hexameric LysB28ProB29-human insulin

1 reference

12 December 2020

Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group.

1 reference

12 December 2020

Severe antibody-mediated human insulin resistance: successful treatment with the insulin analog lispro. A case report

1 reference

12 December 2020

Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.

1 reference

12 December 2020

Metabolic efficacy of preprandial administration of Lys(B28), Pro(B29) human insulin analog in IDDM patients. A comparison with human regular insulin during a three-meal test period.

1 reference

12 December 2020

[Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin

1 reference

12 December 2020

Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes

1 reference

12 December 2020

Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin

1 reference

12 December 2020

Exercise-induced hypoglycaemia in IDDM patients treated with a short-acting insulin analogue.

1 reference

12 December 2020

Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM

1 reference

12 December 2020

Effect of the insulin analogue [LYS(B28),PRO(B29)] on blood glucose control

1 reference

12 December 2020

Strategies toward improved control during insulin lispro therapy in IDDM. Importance of basal insulin.

1 reference

12 December 2020

Postprandial treatment with Lispro insulin

1 reference

12 December 2020

Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Pharmacodynamics of insulin Lispro in 2 patients with type II diabetes mellitus

1 reference

12 December 2020

Comparison of LysB28, ProB29-human insulin analog and regular human insulin in the correction of incidental hyperglycemia

1 reference

12 December 2020

Preparation of an insulin with improved pharmacokinetics relative to human insulin through consideration of structural homology with insulin-like growth factor I.

1 reference

12 December 2020

Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus

1 reference

12 December 2020

Altering the association properties of insulin by amino acid replacement

1 reference

12 December 2020

Severe insulin resistance treated with insulin lispro

1 reference

12 December 2020

Pre-meal insulin analogue insulin lispro vs Humulin R insulin treatment in young subjects with type 1 diabetes.

1 reference

12 December 2020

Meal composition is a determinant of lispro-induced hypoglycemia in IDDM

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

Resource utilization and costs of care in the diabetes control and complications trial

1 reference

12 December 2020

10.2165/00003495-199754040-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

5 October 2017

1028790811

0 references

1 reference